West Pharmaceutical Services Inc
WST
Revenue
746.90M
▲44.80M▲6.38%
3 Months ChangeAssets
3.68B
▲185.70M▲5.32%
3 Months ChangeLiabilities
923.00M
▲10.40M▲1.14%
3 Months ChangeFree Cash Flow
27.60M
▼-28.40M▼-50.71%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 10-Q
ID: 0000105770-24-000081
2024-10-24
Form 8-K
ID: 0000105770-24-000075
2024-10-07
Form 8-K
ID: 0000105770-24-000071
2024-07-25
Form 10-Q
ID: 0000105770-24-000066
2024-07-25
Form 8-K
ID: 0000105770-24-000060
2024-07-08
Form 8-K
ID: 0000105770-24-000055
2024-04-26
Form 8-K
ID: 0000105770-24-000035
2024-04-25
Form 10-Q
ID: 0000105770-24-000031
2024-04-25
Form 8-K
ID: 0000105770-24-000025
2024-02-15
Form 8-K
ID: 0000105770-24-000009